Prior studies suggest that clinical trials are often hampered by problems in design, conduct,
and reporting that limit their uptake in clinical practice. We have described ‘informativeness’ …

Background: Many patients participate in cancer trials to access new therapies. The extent
to which new treatments produce clinical benefit for trial participants is unclear. Purpose: To …

Objective Drug developers sometimes launch phase 3 (P3) trials without supporting evidence
from phase 2 (P2) trials, a practice we call “P2 bypass”. The aims of this study were to …

METHODS We identified experts through the contact network of the vaccinologist author
BJW and corresponding author searches for review articles on vaccinology in highly cited …

Background Prior studies suggest that clinical trials are often hampered by problems in
design, conduct and reporting that limit their uptake in clinical practice. We have described “…

Objectives Compare lay expectations of medical development to those of experts in the context
of SARS-CoV-2 vaccine development. Methods A short online survey of experts and lay …

Objective: Pivotal trials for neurologic drugs in clinical development are often launched absent
support from positive phase 2 trials. Such “phase 2 bypass” may degrade risk/benefit for …

This study was carried out to look at one potential cause for the large number of problems
associated with medication mismanagement of hospitalized older adults. The purpose of this …

… In addition, I would like to thank Barbara Tanner-Brooks and Hannah Moyer, from the SLU
InterLibrary Loan department, for their gracious assistance in obtaining numerous articles for …

The global outbreak of coronavirus disease 2019 (COVID-19) has seen a deluge of clinical
studies, with hundreds registered on clinicaltrials.gov . But a palpable sense of urgency and …